Henry Schein (NASDAQ:HSIC) Research Coverage Started at Citigroup

Citigroup started coverage on shares of Henry Schein (NASDAQ:HSIC) in a research report released on Wednesday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $100.00 price objective on the stock.

Several other research firms have also recently weighed in on HSIC. Mizuho raised their price objective on shares of Henry Schein from $81.00 to $88.00 and gave the company a “neutral” rating in a research report on Wednesday, February 25th. BTIG Research started coverage on shares of Henry Schein in a research report on Thursday. They set a “neutral” rating on the stock. Morgan Stanley increased their price target on shares of Henry Schein from $58.00 to $61.00 and gave the company an “underweight” rating in a research note on Wednesday, February 25th. Wall Street Zen cut shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 14th. Finally, UBS Group upped their price objective on Henry Schein from $79.00 to $87.00 and gave the stock a “neutral” rating in a report on Wednesday, February 25th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Henry Schein has an average rating of “Hold” and a consensus price target of $86.69.

Henry Schein Price Performance

Shares of HSIC stock opened at $78.83 on Wednesday. Henry Schein has a 12 month low of $61.94 and a 12 month high of $89.29. The company has a market capitalization of $9.05 billion, a P/E ratio of 24.11, a P/E/G ratio of 2.29 and a beta of 0.88. The stock has a 50 day moving average of $76.91 and a two-hundred day moving average of $73.95. The company has a current ratio of 1.38, a quick ratio of 0.76 and a debt-to-equity ratio of 0.59.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.04. The business had revenue of $3.44 billion for the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The firm’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.19 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, equities analysts expect that Henry Schein will post 4.74 EPS for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, EVP Mark E. Mlotek sold 5,925 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $80.80, for a total value of $478,740.00. Following the completion of the sale, the executive vice president owned 80,554 shares of the company’s stock, valued at approximately $6,508,763.20. This represents a 6.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kurt P. Kuehn sold 2,844 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $78.96, for a total transaction of $224,562.24. Following the completion of the sale, the director owned 15,420 shares in the company, valued at approximately $1,217,563.20. This trade represents a 15.57% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 105,911 shares of company stock valued at $8,574,982 over the last quarter. 1.08% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the stock. CYBER HORNET ETFs LLC bought a new position in Henry Schein in the second quarter valued at $25,000. MUFG Securities EMEA plc bought a new stake in Henry Schein during the 2nd quarter worth about $27,000. Flagship Harbor Advisors LLC acquired a new position in shares of Henry Schein during the 4th quarter worth about $30,000. Federated Hermes Inc. acquired a new position in shares of Henry Schein during the 4th quarter worth about $32,000. Finally, Los Angeles Capital Management LLC bought a new position in shares of Henry Schein in the 4th quarter valued at about $37,000. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.